Variant report
Variant | esv1801641 |
---|---|
Chromosome Location | chr19:56268219-56289505 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:114)
- CpG islands (count:306)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:56269246-56269296 | ProgFib | skin: | n/a |
2 | chr19:56269246-56269296 | ProgFib | skin: | n/a |
3 | chr19:56269259-56269309 | SK-N-SH_RA | brain: | n/a |
4 | chr19:56269259-56269309 | PFSK-1 | brain: | n/a |
5 | chr19:56269246-56269296 | AG10803 | skin: | n/a |
6 | chr19:56270729-56270779 | AG09309 | skin: | n/a |
7 | chr19:56270498-56270548 | SK-N-MC | brain: | n/a |
8 | chr19:56269259-56269309 | NT2-D1 | testis: | n/a |
9 | chr19:56269259-56269309 | HAEpiC | amniotic membrane: | n/a |
10 | chr19:56274428-56274478 | PFSK-1 | brain: | n/a |
11 | chr19:56270498-56270548 | SAEC | small airway: | n/a |
12 | chr19:56269246-56269296 | RPTEC | kidney: | n/a |
13 | chr19:56269246-56269296 | AoSMC | blood vessel: | n/a |
14 | chr19:56274428-56274478 | HCM | heart: | n/a |
15 | chr19:56274428-56274478 | MCF-7 | breast: | n/a |
16 | chr19:56274428-56274478 | GM19239 | blood: | n/a |
17 | chr19:56269246-56269296 | MCF10A-Er-Src | breast: | n/a |
18 | chr19:56274428-56274478 | GM06990 | blood: | n/a |
19 | chr19:56269246-56269296 | HCM | heart: | n/a |
20 | chr19:56269246-56269296 | Hepatocyte | liver: | n/a |
21 | chr19:56270498-56270548 | HepG2 | liver: | n/a |
22 | chr19:56270729-56270779 | GM19239 | blood: | n/a |
23 | chr19:56270498-56270548 | NT2-D1 | testis: | n/a |
24 | chr19:56270498-56270548 | HNPCEpiC | eye: | n/a |
25 | chr19:56269259-56269309 | AG04450 | lung: | fetal |
26 | chr19:56269246-56269296 | AG04449 | skin: | fetal |
27 | chr19:56269246-56269296 | GM12891 | blood: | n/a |
28 | chr19:56274428-56274478 | NB4 | blood: | n/a |
29 | chr19:56270729-56270779 | Caco-2 | colon: | n/a |
30 | chr19:56270498-56270548 | HCF | heart: | n/a |
31 | chr19:56269259-56269309 | HepG2 | liver: | n/a |
32 | chr19:56270498-56270548 | U87 | brain: | n/a |
33 | chr19:56274428-56274478 | A549 | lung: | n/a |
34 | chr19:56274428-56274478 | SK-N-SH | brain: | n/a |
35 | chr19:56270729-56270779 | NHDF-neo | bronchial: | n/a |
36 | chr19:56269246-56269296 | HEK293 | kidney: | embryo |
37 | chr19:56270498-56270548 | AG04449 | skin: | fetal |
38 | chr19:56269259-56269309 | HRPEpiC | eye: | n/a |
39 | chr19:56270498-56270548 | NHBE | bronchial: | n/a |
40 | chr19:56274428-56274478 | ECC-1 | luminal epithelium: | n/a |
41 | chr19:56270498-56270548 | ECC-1 | luminal epithelium: | n/a |
42 | chr19:56270498-56270548 | AG09309 | skin: | n/a |
43 | chr19:56274428-56274478 | AoSMC | blood vessel: | n/a |
44 | chr19:56270729-56270779 | HUVEC | blood vessel: | n/a |
45 | chr19:56269259-56269309 | U87 | brain: | n/a |
46 | chr19:56274428-56274478 | LNCaP | prostate: | n/a |
47 | chr19:56270729-56270779 | H1-hESC | embryonic stem cell: | embryo |
48 | chr19:56270729-56270779 | PANC-1 | pancreas: | n/a |
49 | chr19:56270729-56270779 | HRCEpiC | kidney: | n/a |
50 | chr19:56269246-56269296 | HIPEpiC | eye: | n/a |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:41464575..41466240-chr19:56288867..56290367,2 | K562 | blood: | |
2 | chr19:56288962..56289563-chr19:56320651..56321410,3 | MCF-7 | breast: | |
3 | chr19:56271991..56273573-chr19:56281048..56283702,2 | K562 | blood: | |
4 | chr19:56271991..56273573-chr19:56281048..56283702,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RFPL4AL1 | TF binding region |
RFPL4AP1 | TF binding region |
RFPL4A | TF binding region |
RFPL4AL1 | CpG island |
RFPL4AP1 | CpG island |
RFPL4A | CpG island |
ENSG00000188825 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555949466 | chr19:56268243-56268244 | Enhancers ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs535528301 | chr19:56268266-56268267 | Enhancers ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs574405238 | chr19:56268267-56268268 | Enhancers ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs12151299 | chr19:56268284-56268285 | Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs572673320 | chr19:56268301-56268302 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
6 | rs28666018 | chr19:56268316-56268317 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
7 | rs368233651 | chr19:56268335-56268336 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375792832 | chr19:56268384-56268385 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200281725 | chr19:56268410-56268411 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs12151301 | chr19:56268432-56268433 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs578169234 | chr19:56268441-56268442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs143831753 | chr19:56268447-56268448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565148499 | chr19:56268455-56268456 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116282372 | chr19:56268462-56268463 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529285201 | chr19:56268464-56268465 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549058805 | chr19:56268485-56268486 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376712936 | chr19:56268498-56268499 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532535294 | chr19:56268511-56268512 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190027997 | chr19:56268513-56268514 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs74591964 | chr19:56268552-56268553 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs79887196 | chr19:56268554-56268555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs113156810 | chr19:56268574-56268575 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs78419801 | chr19:56268583-56268584 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539692080 | chr19:56268588-56268589 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549835865 | chr19:56268594-56268595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141859721 | chr19:56268595-56268596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530140565 | chr19:56268600-56268601 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12977935 | chr19:56268615-56268616 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs117589742 | chr19:56268631-56268632 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs117640224 | chr19:56268638-56268639 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558300755 | chr19:56268646-56268647 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs57811722 | chr19:56268653-56268654 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs57857732 | chr19:56268662-56268663 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544080739 | chr19:56268674-56268675 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182257603 | chr19:56268675-56268676 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs79559880 | chr19:56268682-56268683 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs199634619 | chr19:56268738-56268739 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs186358083 | chr19:56268741-56268742 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559332477 | chr19:56268761-56268762 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528553199 | chr19:56268796-56268797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545194345 | chr19:56268799-56268800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564285485 | chr19:56268800-56268801 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200639151 | chr19:56268819-56268820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs28648033 | chr19:56268833-56268834 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs550046042 | chr19:56268842-56268843 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10425527 | chr19:56268863-56268864 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs529212523 | chr19:56268881-56268882 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs549736236 | chr19:56268893-56268894 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs370826662 | chr19:56268912-56268913 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs386811102 | chr19:56268917-56268918 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 20459607 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Heart disease | 21282601 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21509527 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:56268000-56269800 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr19:56268200-56268400 | ZNF genes & repeats | Liver | Liver |
3 | chr19:56268200-56268400 | Enhancers | Pancreas | Pancrea |
4 | chr19:56268400-56272600 | Weak transcription | Liver | Liver |
5 | chr19:56269800-56270200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
6 | chr19:56270200-56271800 | Enhancers | Primary monocytes fromperipheralblood | blood |
7 | chr19:56272600-56272800 | Active TSS | Liver | Liver |
8 | chr19:56277000-56279600 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr19:56278000-56278200 | Bivalent Enhancer | Primary hematopoietic stem cells short term culture | blood |
10 | chr19:56279600-56280000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
11 | chr19:56280000-56281800 | Enhancers | Primary monocytes fromperipheralblood | blood |
12 | chr19:56281200-56281800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |